BSP Pharmaceuticals S.p.A. is proud to announce Its participation to the annual event of Neo-Synth: Precision Blood Cancer Summit of San Francisco.
This event provides an unique networking opportunity to stakeholder across the R&D value chain to discuss key issues and propose solutions to common challenges.
The Blood cancer R&D represents an enormous opportunity for drug developers, driven by Innovative Cancer Treatment Therapies.
The 'Precision Blood Cancer' Summit will be the next SEPTEMBER 18 – 19 2018 at Crowne Plaza San Francisco (USA). During the Summit, the principal topic to discussion will revolve around all the latest trends in personalized medicine, as pertaining to this disease area, through case studies from early discovery to clinical development.
Meanwhile, the other key topics of the Summit will be:
Save the Date!!! During the Morning Session on Tuesday 18th of September, from 9.00 AM to 10.30 AM, Giorgio Salciarini (Technical Business Development Manager) will make the presentation: “Manufacturing of ADCs: challenges in scaling up DS and DP Process from clinical to commercial”
To request a meeting, You can send an e-mail at email@example.com